Canadian Manufacturing

Medicom to produce more N95 respirators in Quebec

by CM Staff   

Manufacturing Research & Development Sales & Marketing Supply Chain Public Sector COVID-19 health care N95 Production


More than 40 new full-time jobs will be created at the Saint-Laurent plant and new machinery will be installed to support the new production rate. 

Quebec Health Minister Christian Dubé visits Medicom. Pictured: Luc Desbiens, Assistant Deputy Minister of Infrastructure, Logistics, Equipment & Procurement at MSSS, Gopinath Jeyabalaratnam, Medicom Director of Public Affairs , Guillaume Laverdure, Medicom COO, Dominique Lavoie, Deputy Minister at MSSS, Julianna Egressy, Medicom V.P. of Supply Chain, Christian Dubé, Minister of Health and Social Services of Quebec, John Tourlas, Medicom President North America. Photo: Philipp Boulanov (CNW Group/AMD Medicom Inc.)

MONTREAL — Quebec Minister of Health and Social Services, Mr. Christian Dubé, visited Quebec-based AMD Medicom Inc., where the company’s Saint-Laurent plant has reportedly accelerated production of the SafeMask Architect Pro N95 respirator.

Since the outbreak of the Omicron variant and the ensuing increased use of N95 respirators across Canada and the rest of North America, Medicom stated that it has accelerated local production of these medical devices. The company also stated that more than 40 new full-time jobs will be created at the Saint-Laurent plant and new machinery will be installed to support the new production rate.

“Medicom will now supply nearly 3.3 million N95 respirators to the Quebec healthcare system, which is nearly twice the number provided for in our multi-year agreement with the government. In a few weeks, once the new machines are running at full capacity, Medicom will supply the government with more than 4.4 million N95 respirators per month. This is clear evidence that the Quebec government’s local mask procurement strategy is working,” said Guillaume Laverdure, Chief Operating Officer of Medicom in a statement.

Advertisement

Advertisement

Stories continue below